Molecular mechanisms of protein-cholesterol interactions in plasma membranes: Functional distinction between topological (tilted) and consensus (CARC/CRAC) domains

Chemistry and Physics of Lipids

Volumn 199, Issue , 2016, Pages 52-60

  Fantini, Jacques ^a   Di Scala, Coralie ^a   Baier, Carlos J ^b   Barrantes, Francisco J ^b  

^a Aix Marseille University   (France)

^b PONTIFICIA UNIVERSIDAD CATÓLICA ARGENTINA   (Argentina)

Author keywords

Cholesterol; Cholesterol consensus motifs; Cholesterol lipid interactions; Protein lipid interactions

Indexed keywords

CHOLESTEROL; HYDROGEN; MEMBRANE RECEPTOR; PROTEIN; MEMBRANE PROTEIN;

ARTICLE; CELL MEMBRANE; CONSENSUS SEQUENCE; HOST CELL; HUMAN; HYDROGEN BOND; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LIPID INTERACTION; PROTEIN MOTIF; AMINO ACID SEQUENCE; CHEMISTRY; METABOLISM;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; CELL MEMBRANE; CHOLESTEROL; CONSENSUS SEQUENCE; HUMANS; MEMBRANE PROTEINS; PROTEIN DOMAINS;

EID: 84962129908     PISSN: 00093084     EISSN: 18732941     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2016.02.009     Document Type: Article

References (54)

1. Baier, C.J., Fantini, J., Barrantes, F.J., Disclosure of cholesterol recognition motifs in transmembrane domains of the human nicotinic acetylcholine receptor. Sci. Rep., 1, 2011, 69.
2. Blumenthal, R., Durell, S., Viard, M., HIV entry and envelope glycoprotein-mediated fusion. J. Biol. Chem. 287 (2012), 40841–40849.
3. Brasseur, R., Pillot, T., Lins, L., Vandekerckhove, J., Rosseneu, M., Peptides in membranes: tipping the balance of membrane stability. Trends Biochem. Sci. 22 (1997), 167–171.
4. Brasseur, R., Tilted peptides: a motif for membrane destabilization (hypothesis). Mol. Membr. Biol. 17 (2000), 31–40.
5. Brown, D.A., London, E., Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14 (1998), 111–136.
6. Brown, R.E., Sphingolipid organization in biomembranes: what physical studies of model membranes reveal. J. Cell Sci. 111 (1998), 1–9.
7. Charloteaux, B., Lorin, A., Brasseur, R., Lins, L., The Tilted Peptide Theory links membrane insertion properties and fusogenicity of viral fusion peptides. Protein Pept. Lett. 16 (2009), 8–725.
8. Clay, A.T., Lu, P., Sharom, F.J., Interaction of the P-glycoprotein multidrug transporter with sterols. Biochemistry 54 (2015), 6586–6597.
9. Crowet, J.M., et al. Tilted properties of the 67–78 fragment of alpha-synuclein are responsible for membrane destabilization and neurotoxicity. Proteins 68 (2007), 6–947.
10. Di Scala, C., et al. Biochemical identification of a linear cholesterol-binding domain within Alzheimer's beta amyloid peptide. ACS Chem. Neurosci. 4 (2013), 509–517.
11. Di Scala, C., Chahinian, H., Yahi, N., Garmy, N., Fantini, J., Interaction of alzheimer's beta-amyloid peptides with cholesterol: mechanistic insights into amyloid pore formation. Biochemistry 53 (2014), 4489–4502.
12. Di Scala, C., et al. Mechanism of cholesterol-assisted oligomeric channel formation by a short Alzheimer beta-amyloid peptide. J. Neurochem. 128 (2014), 186–195.
13. Epand, R.F., et al. Juxtamembrane protein segments that contribute to recruitment of cholesterol into domains. Biochemistry 45 (2006), 6105–6114.
14. Epand, R.M., Cholesterol and the interaction of proteins with membrane domains. Prog. Lipid Res. 45 (2006), 279–294, 10.1016/j.plipres.2006.02.001.
15. Epand, R.M., Proteins and cholesterol-rich domains. Biochim. Biophys. Acta 1778 (2008), 1576–1582.
16. Fantini, J., Barrantes, F.J., Sphingolipid/cholesterol regulation of neurotransmitter receptor conformation and function. Biochim. Biophys. Acta 1788 (2009), 2345–2361.
17. Fantini, J., Barrantes, F.J., How cholesterol interacts with membrane proteins: an exploration of cholesterol-binding sites including CRAC, CARC, and tilted domains. Front. Physiol., 4, 2013, 31.
18. Fantini, J., Yahi, N., Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseases. Exp. Rev. Mol. Med., 12, 2010, e27.
19. Fantini, J., Yahi, N., The driving force of alpha-synuclein insertion and amyloid channel formation in the plasma membrane of neural cells: key role of ganglioside- and cholesterol-binding domains. Adv. Exp. Med. Biol. 991 (2013), 15–26.
20. Fantini, J., Yahi, N., Brain lipids in synaptic function and neurological disease. Clues to Innovative Therapeutic Strategies for Brain Disorders, 2015, Elsevier Academic Press, San Francisco.
21. Fantini, J., Garmy, N., Mahfoud, R., Yahi, N., Lipid rafts: structure, function and role in HIV, Alzheimer's and prion diseases. Exp. Rev. Mol. Med. 4 (2002), 1–22.
22. Fantini, J., Carlus, D., Yahi, N., The fusogenic tilted peptide (67–78) of alpha-synuclein is a cholesterol binding domain. Biochim. Biophys. Acta 1808 (2011), 2343–2351.
23. Fantini, J., Yahi, N., Garmy, N., Cholesterol accelerates the binding of Alzheimer's beta-amyloid peptide to ganglioside GM1 through a universal hydrogen-bond-dependent sterol tuning of glycolipid conformation. Front. Physiol., 4, 2013, 120.
24. Fantini, J., et al. Bexarotene blocks calcium-permeable ion channels formed by neurotoxic Alzheimer's ss-amyloid peptides. ACS Chem. Neurosci. 5 (2014), 216–224.
25. Fantini, J., Di Scala, C., Evans, L.S., Williamson, P.T., Barrantes, F., A mirror code for protein-cholesterol interactions in the two leaflets of biological membranes. Sci. Rep., 6, 2016, 21907.
26. Fantini, J., How sphingolipids bind and shape proteins: molecular basis of lipid-protein interactions in lipid shells, rafts and related biomembrane domains. Cell. Mol. Life Sci. 60 (2003), 1027–1032.
27. Farrand, A.J., LaChapelle, S., Hotze, E.M., Johnson, A.E., Tweten, R.K., Only two amino acids are essential for cytolytic toxin recognition of cholesterol at the membrane surface. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 4341–4346.
28. Gal, Z., et al. Mutations of the central tyrosines of putative cholesterol recognition amino acid consensus (CRAC) sequences modify folding, activity, and sterol-sensing of the human ABCG2 multidrug transporter. Biochim. Biophys. Acata 1848 (2015), 477–487.
29. Hanson, M.A., et al. A specific cholesterol binding site is established by the 2: 8A structure of the human beta2-adrenergic receptor. Structure 16 (2008), 897–905.
30. Harris, J.S., Epps, D.E., Davio, S.R., Kezdy, F.J., Evidence for transbilayer, tail-to-tail cholesterol dimers in dipalmitoylglycerophosphocholine liposomes. Biochemistry 34 (1995), 3851–3857.
31. Harrison, S.C., Viral membrane fusion. Virology 479–480 (2015), 498–507.
32. Jang, H., et al. Alzheimer's disease: which type of amyloid-preventing drug agents to employ?. Phys. Chem. Chem. Phys. 15 (2013), 8868–8877.
33. Lal, R., Lin, H., Quist, A.P., Amyloid beta ion channel: 3D structure and relevance to amyloid channel paradigm. Biochim. Biophys. Acta 1768 (2007), 1966–1975.
34. Lee, A.G., How lipids affect the activities of integral membrane proteins. Biochim. Biophys. Acta 1666 (2004), 62–87.
35. Leventis, P.A., Grinstein, S., The distribution and function of phosphatidylserine in cellular membranes. Annu. Rev. Biophys. 39 (2010), 407–427.
36. Levitan, I., Singh, D.K., Rosenhouse-Dantsker, A., Cholesterol binding to ion channels. Front. Physiol., 5, 2014, 65.
37. Li, H., Papadopoulos, V., Peripheral-type benzodiazepine receptor function in cholesterol transport: identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology 139 (1998), 4991–4997.
38. Lins, L., Brasseur, R., Tilted peptides: a structural motif involved in protein membrane insertion?. J. Pept. Sci. 14 (2008), 416–422.
39. Maresca, M., Derghal, A., Caravagna, C., Dudin, S., Fantini, J., Controlled aggregation of adenine by sugars: physicochemical studies, molecular modelling simulations of sugar-aromatic CH-pi stacking interactions, and biological significance. Phys. Chem. Chem. Phys. 10 (2008), 2792–2800.
40. Nishio, M., Umezawa, Y., Fantini, J., Weiss, M.S., Chakrabarti, P., CH–π hydrogen bonds in biological macromolecules. Phys. Chem. Chem. Phys. 16 (2014), 12648–12683.
41. Paila, Y.D., Tiwari, S., Chattopadhyay, A., Are specific nonannular cholesterol binding sites present in G-protein coupled receptors?. Biochim. Biophys. Acta 1788 (2009), 295–302.
42. Palmer, M., Cholesterol and the activity of bacterial toxins. FEMS Microbiol. Lett. 238 (2004), 281–289.
43. Pike, L.J., Han, X., Chung, K.N., Gross, R.W., Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis. Biochemistry 41 (2002), 2075–2088.
44. Quiocho, F.A., Carbohydrate-binding proteins: tertiary structures and protein-sugar interactions. Annu. Rev. Biochem. 55 (1986), 287–315.
45. Quist, A., et al. Amyloid ion channels: a common structural link for protein-misfolding disease. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 10427–10432.
46. Radhakrishnan, A., Anderson, T.G., McConnell, H.M., Condensed complexes, rafts, and the chemical activity of cholesterol in membranes. Proc. Natl. Acad. Sci. U. S. A. 97 (2000), 12422–12427.
47. Ramstedt, B., Slotte, J.P., Interaction of cholesterol with sphingomyelins and acyl-chain-matched phosphatidylcholines: a comparative study of the effect of the chain length. Biophys. J. 76 (1999), 908–915.
48. Rosenhouse-Dantsker, A., Noskov, S., Durdagi, S., Logothetis, D.E., Levitan, I., Identification of novel cholesterol-binding regions in Kir2 channels. J. Biol. Chem. 288 (2013), 31154–31164.
49. Schroeder, C., Cholesterol-binding viral proteins in virus entry and morphogenesis. Subcell. Biochem. 51 (2010), 7–108.
50. Sharpe, L.J., et al. Cholesterol sensing by the ABCG1 lipid transporter: requirement of a CRAC motif in the final transmembrane domain. Biochim. Biophys. Acta 1851 (2015), 956–964.
51. Simons, K., Ikonen, E., Functional rafts in cell membranes. Nature 387 (2016), 569–572.
52. Strandberg, E., Killian, J.A., Snorkeling of lysine side chains in transmembrane helices: how easy can it get?. FEBS Lett. 544 (2003), 69–73.
53. Telbisz, A., Hegedus, C., Varadi, A., Sarkadi, B., Ozvegy-Laczka, C., Regulation of the function of the human ABCG2 multidrug transporter by cholesterol and bile acids: effects of mutations in potential substrate and steroid binding sites. Drug Metab. Dispos. 42 (2014), 575–585.
54. Wudiri, G.A., et al. Molecular requirement for sterols in herpes simplex virus entry and infectivity. J. Virol. 88 (2014), 13918–13922.